A Clinician’s Guide to HCV Treatment in the Primary Care Setting: A Multimedia eHealth Source™ Educational Initiative

By Sherilyn Brinkley, MSN, CRNP and Graham Foster, FRCP, PhD

The ability to treat and cure hepatitis C virus (HCV) infection is one of the greatest achievements of modern medicine. The simplified guidelines and the availability of highly effective and manageable direct-acting antiviral agents (DAA) regimens make it increasingly feasible to treat uncomplicated HCV in the primary care setting. This HCV eHealth Source™ activity was developed to empower primary care clinicians, who are ideally positioned to lead frontline efforts to achieve the worldwide goal of eliminating HCV. Practices such as universal screening for HCV, the implementation of treatment regimens, and strategies for supporting, as well as monitoring, patients post-cure will be provided.

• Language: English
• Publisher: Integritas Communications
• Release date: Jul 19, 2022

Book preview

Faculty

Sherilyn C. Brinkley, MSN, CRNP

Nurse Practitioner/Program Manager

Clinical Services and Research, Viral Hepatitis Center

Johns Hopkins University School of Medicine

Baltimore, Maryland

Ms. Sherilyn Brinkley is Nurse Practitioner Manager and Program Manager of Clinical Services and Research at the Viral Hepatitis Center at the Johns Hopkins University (JHU) School of Medicine. She has clinical expertise in the care of persons with hepatitis B, hepatitis C, and human immunodeficiency virus (HIV) coinfections. Having served as a Clinical Nurse for an HIV/acquired immune deficiency syndrome (AIDS)-dedicated unit at Johns Hopkins Hospital in the 1990s and as a Community Health Nurse for the AmeriCorps Service Program at the university’s School of Nursing, she has over 20 years of direct patient care and research experience working to eradicate hepatitis C and deliver curative therapies to the Baltimore community. She developed a multidisciplinary viral hepatitis clinical care team that included a walk-in outpatient program to improve hepatitis C screening and linkage to care.

Ms. Brinkley is the author or coauthor of abstracts and publications on viral hepatitis and has presented on the management and delivery of viral hepatitis clinical care at national medical meetings. She was the recipient of the 1st Annual Miller Coulson Nurse Practitioner Clinical Excellence Award in 2015 and the 2012 Hepatitis Hero Award, presented by the Maryland Hepatitis Coalition. She earned her bachelor’s and master’s of science degrees from the JHU School of Nursing and is a member of the Sigma Theta Tau Nursing Honor Society (Nu Beta chapter), the American Association of Nurse Practitioners, and the American Association for the Study of Liver Diseases (AASLD).

Graham Foster, FRCP, PhD

Professor of Hepatology

Queen Mary University of London

Consultant Hepatologist

Barts Health NHS Trust

London, United Kingdom

Dr. Graham Foster is a Professor of Hepatology at Queen Mary University of London and a consultant at Barts Health in East London. He trained in Medicine at Oxford and London Universities in the 1980s and completed a PhD in Molecular Biology in 1992. Professor Foster has a long-standing interest in the management of chronic viral hepatitis and runs a clinical research program studying the natural history of viral hepatitis, its impact on patients and their communities, and novel therapies for this disease. He leads an international study investigating community screening for viral hepatitis and supervises a laboratory research program investigating novel replication models for hepatitis C. Editor of the Journal of Viral Hepatitis, he has published widely in the field of viral liver disease. He is a past President of the British Association for the Study of the Liver (BASL), past chairman of the National Health Service England (NHSE) Hepatobiliary Clinical Reference Group, and Clinical Lead for the NHSE Hepatitis C Programme.

Preamble

Target Audience

The educational design of this activity addresses the needs of family medicine, internal medicine, and general practice clinicians involved in the treatment of patients with hepatitis C virus.

Program Overview

The ability to treat and cure hepatitis C virus (HCV) infection is one of the greatest achievements of modern medicine. The simplified guidelines and the availability of highly effective and manageable direct-acting antiviral agents (DAA) regimens make it increasingly feasible to treat uncomplicated HCV in the primary care setting. This HCV eHealth Source™ activity was developed to empower primary care clinicians, who are ideally positioned to lead frontline efforts to achieve the worldwide goal of eliminating HCV. Practices such as universal screening for HCV, the